Serum levels of squamous cell carcinoma antigens 1 and 2 reflect disease severity and clinical type of atopic dermatitis in adult patients
Author(s) -
Tomoko Okawa,
Yukie Yamaguchi,
Kenzen Kou,
Junya Ono,
Yoshinori Azuma,
Noriko Komitsu,
Yusuke Inoue,
Masumi Kohno,
Setsuko Matsukura,
Takeshi Kambara,
Shoichiro Ohta,
Kenji Izuhara,
Michiko Aihara
Publication year - 2017
Publication title -
allergology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.49
H-Index - 58
eISSN - 1440-1592
pISSN - 1323-8930
DOI - 10.1016/j.alit.2017.06.016
Subject(s) - atopic dermatitis , immunology , biomarker , immunoglobulin e , medicine , eosinophil , antigen , biology , antibody , asthma , biochemistry
Recent studies have indicated that serum levels of squamous cell carcinoma antigen (SCCA) 1 and 2 induced by type 2 cytokines such as IL-4 and IL-13, are increased in patients with atopic dermatitis (AD). However, no clinical studies have analyzed serum levels of SCCA2 in larger series of AD patients or their association with various clinical characteristics. This study was performed to clarify whether serum levels of SCCA2 are associated with disease severity and clinical phenotypes of adult AD patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom